Cedars-Sinai Medical Center is an 886-bed non-profit, acute, quaternary, teaching Level I Trauma Center hospital located in the heart of Los Angeles, California. The Cedars Sinai Cancer Center is ranked #12 in the Nation by the U.S. News & World Report. The Department of Pharmacy has over approximately 430 staff members who provide comprehensive inpatient pharmacy services as well as outpatient services via 2 cancer centers and 3 outpatient pharmacies. The Department of Pharmacy is committed to the education and training of pharmacists, students/interns, residents, technicians, and other health care professionals. Cedars-Sinai Medical Center (CSMC) is affiliated with several Schools of Pharmacy and offers PGY1 and PGY2 residency programs. The residency and student experiential programs at CSMC continue to grow with every successive year, where nearly 100 residents have graduated from the PGY1 pharmacy residency program since 1985 and more than 200 student rotations are offered at CSMC annually. Recently, CSMC was recognized and bestowed "Site of the Year" awards by two major affiliated CA Schools of Pharmacy for providing an exceptional experiential learning environment for their students.

As an Oncology Outpatient Pharmacist at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, you will be providing comprehensive direct patient care to leukemia, lymphoma, and other cancer patients. You will assist with management of adult patients, including: oral chemotherapy management, therapeutic drug monitoring; approved pharmacy managed protocols; review of chemotherapy orders; and provision of drug information and optimizing drug therapy. You will also be involved in the review of research protocols and oversight of research medications.

The Oncology Pharmacist will provide support for oncology diagnosis-related group guideline development, updates and new drug monographs. You will be presenting quarterly summaries of diagnosis-related group updates at the Oncology P&T subcommittee meetings. You will provide patient education and follow up to the growing oral chemotherapy specialty pharmacy program.